Infection prophylaxis in peritoneal dialysis patients: Results from an Australia/New Zealand survey

No Thumbnail Available
File version
Author(s)
Campbell, DJ
Mudge, DW
Gallagher, MP
Lim, WH
Ranganathan, D
Saweirs, W
Craig, JC
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2017
Size
File type(s)
Location
License
Abstract

Background: Clinical practice guidelines aim to reduce the rates of peritoneal dialysis (PD)-related infections, a common complication of PD in end-stage kidney disease patients. We describe the clinical practices used by Australian and New Zealand nephrologists to prevent PD-related infections in PD patients. Methods: A survey of PD practices in relation to the use of antibiotic and antifungal prophylaxis in PD patients was conducted of practicing nephrologists identified via the Australia and New Zealand Society of Nephrology (ANZSN) membership in 2013. Results: Of 333 nephrologists approached, 133 (39.9%) participated. Overall, 127 (95.5%) nephrologists prescribed antibiotics at the time of Tenckhoff catheter insertion, 85 (63.9%) routinely screened for nasal S. aureus carriage, with 76 (88.4%) reporting they treated S. aureus carriers with mupirocin ointment. Following Tenckhoff catheter insertion, 79 (59.4%) prescribed mupirocin ointment at the exit site or intranasally, and 93 (69.9%) nephrologists routinely prescribed a course of oral antifungal agent whenever their PD patients were given a course of antibiotics. Conclusions: Although the majority of nephrologists prescribe antibiotics at the time of Tenckhoff catheter insertion, less than 70% routinely prescribe mupirocin ointment and/or prophylactic antifungal therapy. This variation in practice in Australia and New Zealand may contribute to the disparity in PD-related infection rates that is seen between units.

Journal Title

Peritoneal Dialysis International

Conference Title
Book Title
Edition
Volume

37

Issue

2

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Clinical sciences

Antibiotic prophylaxis

antifungal agents

chronic

kidney failure

peritoneal dialysis

Persistent link to this record
Citation

Campbell, DJ; Mudge, DW; Gallagher, MP; Lim, WH; Ranganathan, D; Saweirs, W; Craig, JC, Infection prophylaxis in peritoneal dialysis patients: Results from an Australia/New Zealand survey, Peritoneal Dialysis International, 2017, 37 (2), pp. 191-197

Collections